RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Labgenomics Co Stock

Labgenomics Co Debt 2025

Labgenomics Co Debt

7,763.06 KRW

Ticker

084650.KQ

ISIN

KR7084650001

In 2025, Labgenomics Co's total debt was 7,763.06 KRW, a -63.43% change from the 21,228.12 KRW total debt recorded in the previous year.

Labgenomics Co Aktienanalyse

What does Labgenomics Co do?

Labgenomics Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Labgenomics Co's Debt Structure

Labgenomics Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Labgenomics Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Labgenomics Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Labgenomics Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Labgenomics Co stock

What is the debt of Labgenomics Co this year?

Labgenomics Co has a debt level of 7,763.06 KRW this year.

What was the debt of Labgenomics Co compared to the previous year?

The debt of Labgenomics Co has increased by -63.43% compared to the previous year dropped.

What are the consequences of high debt for investors in Labgenomics Co?

High debt can pose a risk for investors of Labgenomics Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Labgenomics Co?

Low debt means that Labgenomics Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Labgenomics Co affect the company?

An increase in debt of Labgenomics Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Labgenomics Co affect the company?

A reduction in debt of Labgenomics Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Labgenomics Co?

Some factors that can influence the debt of Labgenomics Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Labgenomics Co so important for investors?

The debts of Labgenomics Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Labgenomics Co take to change the debt?

To change the debt, Labgenomics Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Labgenomics Co pay?

Over the past 12 months, Labgenomics Co paid a dividend of 50 KRW . This corresponds to a dividend yield of about 2.3 %. For the coming 12 months, Labgenomics Co is expected to pay a dividend of 19.15 KRW.

What is the dividend yield of Labgenomics Co?

The current dividend yield of Labgenomics Co is 2.3 %.

When does Labgenomics Co pay dividends?

Labgenomics Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Labgenomics Co?

Labgenomics Co paid dividends every year for the past 2 years.

What is the dividend of Labgenomics Co?

For the upcoming 12 months, dividends amounting to 19.15 KRW are expected. This corresponds to a dividend yield of 0.88 %.

In which sector is Labgenomics Co located?

Labgenomics Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Labgenomics Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Labgenomics Co from 4/21/2022 amounting to 300 KRW, you needed to have the stock in your portfolio before the ex-date on 12/29/2021.

When did Labgenomics Co pay the last dividend?

The last dividend was paid out on 4/21/2022.

What was the dividend of Labgenomics Co in the year 2024?

In the year 2024, Labgenomics Co distributed 0 KRW as dividends.

In which currency does Labgenomics Co pay out the dividend?

The dividends of Labgenomics Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Labgenomics Co

Our stock analysis for Labgenomics Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Labgenomics Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.